These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25197925)

  • 1. Letters to the Editor: Assessing the cost-effectiveness of allergen immunotherapy in allergic rhinitis.
    Incorvaia C; Makrì E; Ridolo E
    Am J Rhinol Allergy; 2014; 28(4):353. PubMed ID: 25197925
    [No Abstract]   [Full Text] [Related]  

  • 2. Response.
    Kennedy JL; Borish L; Christophel J; Payne SC
    Am J Rhinol Allergy; 2014; 28(4):353-4. PubMed ID: 25197924
    [No Abstract]   [Full Text] [Related]  

  • 3. Decision-making analysis for allergen immunotherapy versus nasal steroids in the treatment of nasal steroid-responsive allergic rhinitis.
    Kennedy JL; Robinson D; Christophel J; Borish L; Payne S
    Am J Rhinol Allergy; 2014; 28(1):59-64. PubMed ID: 24717886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of allergen-specific immunotherapy for allergic rhinitis].
    Li HB; Xu G
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 46(12):1058-62. PubMed ID: 22336028
    [No Abstract]   [Full Text] [Related]  

  • 5. The health economics of allergen immunotherapy.
    Hankin CS; Cox L; Bronstone A
    Immunol Allergy Clin North Am; 2011 May; 31(2):325-41, x. PubMed ID: 21530823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual.
    Cox L; Wallace D
    Immunol Allergy Clin North Am; 2011 Aug; 31(3):561-99. PubMed ID: 21737043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inadequate health insurance coverage: a major factor in premature discontinuation of subcutaneous immunotherapy for allergic rhinitis.
    Vaswani R; Liu YC; Parikh L; Vaswani S
    Ear Nose Throat J; 2011 Apr; 90(4):170-3. PubMed ID: 21500169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expert consensus on allergen specific immunotherapy of allergic rhinitis].
    ;
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 46(12):976-80. PubMed ID: 22336007
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on allergen immunotherapy for treatment of allergic diseases.
    Kwong KY; Leibel S
    Adv Pediatr; 2013; 60(1):141-65. PubMed ID: 24007843
    [No Abstract]   [Full Text] [Related]  

  • 10. Subcutaneous versus sublingual immunotherapy.
    Lin CH; Alandijani S; Lockey RF
    Expert Rev Clin Immunol; 2016 Aug; 12(8):801-3. PubMed ID: 27253418
    [No Abstract]   [Full Text] [Related]  

  • 11. Fireside conference 7. Immunotherapy for allergic rhinitis.
    Naclerio RM
    Rhinol Suppl; 1992; 14():209-12. PubMed ID: 1389388
    [No Abstract]   [Full Text] [Related]  

  • 12. Allergic rhinitis and immunotherapy.
    Kupa A
    Med J Aust; 1992 Jul; 157(1):9-11. PubMed ID: 1640909
    [No Abstract]   [Full Text] [Related]  

  • 13. Allergen immunotherapy for allergic rhinitis.
    Okubo K; Gotoh M
    J Nippon Med Sch; 2010 Dec; 77(6):285-9. PubMed ID: 21206140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Subcutaneous allergen-specific immunotherapy in patients with asthma and allergic rhinitis. 21st century].
    Martín JP
    Rev Alerg Mex; 2009; 56(2):27-9. PubMed ID: 19526950
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent advances in specific immunotherapy for allergic rhinitis.
    Bousquet J; Hejjaoui A; Michel FB
    Clin Exp Allergy; 1991 Jan; 21 Suppl 1():259-61. PubMed ID: 2032157
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of SIT on quality of life.
    Yilmaz M; Bingöl G; Altintaş D; Kendirli SG
    Allergy; 2000 Mar; 55(3):302. PubMed ID: 10753028
    [No Abstract]   [Full Text] [Related]  

  • 17. Treating allergic rhinitis by sublingual immunotherapy: a review.
    Incorvaia C; Di Rienzo A; Celani C; Makrì E; Frati F
    Ann Ist Super Sanita; 2012; 48(2):172-6. PubMed ID: 22751560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allergen-specific immunotherapy (hyposensitization). Part 2. Oral, sublingual and nasal application].
    Fuchs T; Klimek L
    HNO; 2000 Feb; 48(2):158-64. PubMed ID: 10663067
    [No Abstract]   [Full Text] [Related]  

  • 19. Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study.
    Hankin CS; Cox L; Lang D; Bronstone A; Fass P; Leatherman B; Wang Z
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):79-85. PubMed ID: 20143650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local nasal immunotherapy.
    Andri L; Senna G
    Allergy; 1995 Feb; 50(2):190. PubMed ID: 7604946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.